3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
13
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Neoplasm Metastasis
5
Neoplasms
4
Lung Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
2
Skin Neoplasms
2
Skin Diseases
2
Pancreatic Neoplasms
2
Hematologic Neoplasms
2
Uveal Melanoma
1
Spinocerebellar Degenerations
1
Solid Tumors Harboring a BRAF V600 Mutation
1
Soft Tissue Neoplasms
1
Peripheral Nervous System Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Noonan Syndrome 5
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Multiple Myeloma
1
Lymphoma
1
Lymphatic Metastasis
1
Low-grade Serous Ovarian Cancer
1
Leukemia, Myeloid, Acute
1
Hereditary Sensory and Autonomic Neuropathies
1
Gliosarcoma
1
Interventions
Gemcitabine
31
Cisplatin
21
pembrolizumab
8
Fluorouracil
6
Oxaliplatin
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
durvalumab
4
Taxes
4
Albumin-Bound Paclitaxel
4
pemigatinib
3
infigratinib
3
atezolizumab
3
Specimen Handling
3
Radiosurgery
3
Platinum
3
Magnetic Resonance Spectroscopy
3
Leucovorin
3
Carboplatin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
trametinib
2
olaparib
2
ivosidenib
2
derazantinib
2
cobimetinib
2
Trastuzumab
2
Radiotherapy
2
Panitumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Cholangiocarcinoma
×
binimetinib
×
Clear all
No trials found.